Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Aquestive Therapeutics (AQST)

Annual Return

Over the past 3 years, AQST has had an average annual return of +35.80%, outperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, AQST has had an average annual return of +0.91%, underperforming the benchmark SPY, which returned +12.78% annual.

Since Jul 25, 2018, AQST has had an average annual return of -16.10%, underperforming the benchmark SPY, which returned +14.51% annual.

202620252024202320222021202020192018
-38.93%+81.47%+76.17%+124.02%-76.82%-27.27%-8.08%-7.62%-60.75%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-54.34%+35.58%+3.77%-1.20%-1.96%+3.47%-5.17%-38.93%
2025-15.15%-7.28%+3.55%+0.83%-7.35%+22.16%+16.05%-1.84%+48.28%+21.99%-9.23%+4.36%+81.47%
2024+18.27%+53.59%+16.05%-21.14%-14.29%-9.70%+47.72%+17.93%+9.96%+10.25%-7.31%-30.05%+76.17%
2023-1.25%-12.07%+45.49%+17.61%+72.34%-28.56%+32.68%-25.07%-6.75%+2.62%+43.35%-10.20%+124.02%
2022-30.07%+2.54%-6.44%-46.37%-29.01%-35.54%+28.32%+75.78%-19.00%-25.65%+6.64%-2.77%-76.82%
2021-1.11%-13.41%+13.52%-21.73%-8.83%+7.01%-18.15%+40.94%-4.80%+17.85%+14.80%-34.06%-27.27%
2020-30.42%-7.89%-41.31%+96.85%+13%-0.20%+8.22%+49.44%-38.23%-0.30%+45.86%-24.23%-8.08%
2019-2.70%+31.34%-14.17%-17.35%-34.85%+12.90%-18.80%+11.44%-16.34%+20.80%+102.84%-25.30%-7.62%
2018-6.29%+19.74%-2.77%-13.59%-43.23%-26.66%-60.75%

Drawdown analysis of Aquestive Therapeutics (AQST)

The maximum drawdown for the AQST was -96.67%, occurring on Jul 1, 2022. This drawdown has not yet recovered.

The current AQST drawdown is -79.19%.

Since Jul 25, 2018 AQST has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-96.67%Sep 7, 2018960Jul 1, 2022OngoingOngoingOngoing
-6.54%Jul 25, 20188Aug 6, 20185Aug 13, 201813
-6.17%Aug 14, 20189Aug 27, 20182Aug 29, 201811
-0.67%Aug 31, 20181Sep 4, 20182Sep 6, 20183